Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era

被引:18
作者
Shiba, N
Chan, MCY
Valantine, HA
Gao, SZ
Robbins, RC
Hunt, SA
机构
[1] Stanford Univ, Med Ctr, Div Cardiovasc Med, Stanford, CA 94305 USA
[2] Stanford Univ, Med Ctr, Dept Cardiothorac Surg, Stanford, CA 94305 USA
关键词
D O I
10.1016/S1053-2498(02)01192-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Long-term survival after heart transplantation is common in the cyclosporine era. However, there are few data documenting pre-transplant/perioperative factors predictive of truly long-term survival (>10 years). The purpose of this study is to identify factors associated with 10-year survival after heart transplantation. Methods: Our study population included 197 adults who survived >6 months and died <10 years after heart transplant (medium-term group) and 140 adults who survived >10 years after heart transplant (long-term group) between December 1980 and May 2001. A comparison was done between the two groups and We used multivariate analysis to identify which factors predicted 10-year survival. Results: The long-term group had younger recipient and donor age, lower recipient body mass index at transplant, shorter waiting time and lower percentages of ischemic etiology/male recipient/non-white recipient. Kaplan-Meier plots of freedom from graft coronary artery disease and malignancy showed later onset patterns in the long-term group compared with the medium-term group. Multivariate analysis showed that white recipient, younger recipient and lower recipient body mass index at heart transplant were factors significantly associated with 10-year survival. Conclusions: Several pre-transplant/peri-operative factors were associated with survival beyond 10 years after heart transplantation. Stratified/tailored strategies based on these factors may be helpful to attain longer-term survival of recipients with higher risks.
引用
收藏
页码:1098 / 1106
页数:9
相关论文
共 35 条
[1]   Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: A single-center experience [J].
Adamson, R ;
Obispo, E ;
Dychter, S ;
Dembitsky, W ;
Moreno-Cabral, R ;
Jaski, B ;
Gordon, J ;
Hoagland, P ;
Moore, K ;
King, J ;
Andrews, J ;
Rich, M ;
Daily, PO .
TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) :1107-1109
[2]   Cardiac transplantation for cardiomyopathy and ischemic heart disease: Differences in outcome up to 10 years [J].
Aziz, T ;
Burgess, M ;
Rahman, AN ;
Campbell, CS ;
Yonan, N .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (05) :525-533
[3]  
BAKER AM, 1992, J HEART LUNG TRANSPL, V11, P1156
[4]   Cardiac transplantation in patients over 60 years of age [J].
Baron, O ;
Trochu, JN ;
Treilhaud, M ;
Al Habash, O ;
Remadi, JP ;
Petit, T ;
Duveau, D ;
Despins, P ;
Michaud, JL .
TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :75-78
[5]   An analysis of the effect of age on survival after heart transplant [J].
Borkon, AM ;
Muehlebach, GF ;
Jones, PG ;
Bresnahan, DR ;
Genton, RE ;
Gorton, ME ;
Long, ND ;
Magalski, A ;
Porter, CB ;
Reed, WA ;
Rowe, SK .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (07) :668-674
[6]  
BOURGE RC, 1993, J HEART LUNG TRANSPL, V12, P549
[7]  
CHOCAIR PR, 1993, Q J MED, V86, P359
[8]  
COCANOUGHER B, 1993, TRANSPLANT P, V25, P233
[9]  
Costanzo MR, 1998, J HEART LUNG TRANSPL, V17, P744
[10]  
COSTANZONORDIN MR, 1992, J HEART LUNG TRANSPL, V11, pS90